Invention Grant
- Patent Title: Adoptive cellular therapy
-
Application No.: US17046466Application Date: 2019-04-12
-
Publication No.: US12036256B2Publication Date: 2024-07-16
- Inventor: James Brian Rottman
- Applicant: Regeneron Pharmaceuticals, Inc.
- Applicant Address: US NY Tarrytown
- Assignee: Regeneron Pharmaceuticals, Inc.
- Current Assignee: Regeneron Pharmaceuticals, Inc.
- Current Assignee Address: US NY Tarrytown
- Agency: McCarter & English, LLP
- Agent Marcie B. Clarke, Esq.; Dylan M. Blumenthal
- International Application: PCT/US2019/027317 2019.04.12
- International Announcement: WO2019/200316A 2019.10.17
- Date entered country: 2020-10-09
- Main IPC: A61K35/763
- IPC: A61K35/763 ; A61K39/00 ; A61K39/12 ; A61K39/285 ; A61K39/39 ; A61P35/00 ; C07K14/725 ; C12N7/00
Abstract:
The invention provides improved compositions and methods for the treatment of solid cancers.
Public/Granted literature
- US20210252084A1 ADOPTIVE CELLULAR THERAPY Public/Granted day:2021-08-19
Information query
